ArticleRSC medicinal chemistry2026

Symmetry-guided fusion converts weak liver pyruvate kinase inhibitors into potent allosteric activators.

Leticia Monjas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.